News

To promote drug safety, FDA to replace animal testing with AI-based experiments, other methods
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
FDA says it will phase out animal testing requirement for monoclonal antibodies and drugs
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
US FDA to phase out animal testing in drug development
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
FDA reverses course on telework after layoffs and resignations threaten basic operations
Weeks after ordering all Food and Drug Administration employees back into the office, the agency is reversing course, ...
Key takeaways from RFK Jr.'s interview on measles vaccine, food dyes, weight loss drugs and more
Health and Human Services Secretary Robert F. Kennedy Jr. spoke with CBS News in an exclusive interview. Here are some ...
Trump administration rejects plan for Medicare to cover weight loss drugs
Health and Human Services Secretary Robert F. Kennedy Jr. has been a vocal critic of drugs like Ozempic which he said cloud ...
F.D.A. Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...
BioPharma Dive2h
FDA plans to phase out animal testing for some drugs
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
Mass Layoffs Hit Health Agencies That Track Disease and Regulate Food
The cuts were part of a Trump administration plan announced last week to dismiss thousands of employees and drastically ...
FDA planning for fewer food and drug inspections due to layoffs, officials say
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
STAT22h
Crucial FDA drug reviews expected to be slowed by job cuts
A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.